← European Medicine Shortage Tracker · all medicines

Diosmina + esperidina shortage — availability across Europe

Diosmina + esperidina currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: DIOSMINA + ESPERIDINA · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Diosmina + esperidina has active availability issues in 1 of 10 tracked European registers.
Registers reporting issues: Italy.
Longest-running open report: since 2025-12-15 (8 months, Italy).
Data source: 1 official medicines-agency register, refreshed daily.

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Diosmina + esperidina, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2025-12-15 and has now been open for about 8 months. Where agencies state a cause, manufacturing problems lead with 2 of the 2 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇮🇹 Italy	Shortage ZEFLAVON + 1 more products ZEFLAVON	2025-12-15	—	Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available.	register ↗

New register reports per month

Full report history (2 register entries)

Every individual register entry for Diosmina + esperidina in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	ZEFLAVON	Shortage	2026-04-30	—	Problemi produttivi
🇮🇹 IT	ZEFLAVON	Shortage	2025-12-15	—	Problemi produttivi

Frequently asked

Is Diosmina + esperidina currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Diosmina + esperidina?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Diosmina + esperidina availability data come from?

Directly from the official medicines-agency register that lists Diosmina + esperidina: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Diosmina + esperidina — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/diosmina-esperidina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Diosmina + esperidina availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/diosmina-esperidina/">Diosmina + esperidina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Diosmina + esperidina: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.